i n f l a r x

Loading

Press Release

Home Investors Press Releases Press Release

InflaRx Announces Initiation of Phase III Part of Phase II/III Clinical Trial with IFX-1 in Severe COVID-19 Induced Pneumonia

Sep 14, 2020

Time to read 4 Minutes

Download PDF

Back